Skip to main content
. 2022 May 17;12:8224. doi: 10.1038/s41598-022-11020-2

Figure 4.

Figure 4

Tissue homogenate drug concentration–time profiles following intravenous TAF dosing in C57BL/6 J mice. Blue, TFV; green, TFV-DP. The sampled anatomic compartments are: (A) and (E), vaginal (median tissue mass, 192 mg/sample); (B) and (F) rectal (median tissue mass, 71 mg/sample); (C) and (G) spleen (median tissue mass, 106 mg/sample); and (D) and (H) thymus (median tissue mass, 68 mg/sample). The assay LLOQs are: TFV (based on 0.05 ng/sample), vaginal 0.9 fmol mg-1; rectal, 2.4 fmol mg-1; spleen, 1.6 fmol mg-1; thymus, 2.6 fmol mg-1; TFV-DP (based on 5 fmol/sample), vaginal 0.03 fmol mg-1; rectal, 0.07 fmol mg-1; spleen, 0.05 fmol mg-1; thymus, 0.07 fmol mg-1.